Tomoko Kataoka

1.7k total citations
58 papers, 690 citations indexed

About

Tomoko Kataoka is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Tomoko Kataoka has authored 58 papers receiving a total of 690 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 29 papers in Oncology and 14 papers in Surgery. Recurrent topics in Tomoko Kataoka's work include Gastric Cancer Management and Outcomes (10 papers), Lung Cancer Treatments and Mutations (8 papers) and Cancer Diagnosis and Treatment (8 papers). Tomoko Kataoka is often cited by papers focused on Gastric Cancer Management and Outcomes (10 papers), Lung Cancer Treatments and Mutations (8 papers) and Cancer Diagnosis and Treatment (8 papers). Tomoko Kataoka collaborates with scholars based in Japan, United States and Italy. Tomoko Kataoka's co-authors include Hiroshige Hibasami, Kazumi Yoshioka, Masami Hasegawa, Toshiya Hayashi, Elad Sharon, Paolo Bossi, Anusha Vaddi, Karis Kin Fong Cheng, Abhishek Kandwal and Takahide Komori and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

Tomoko Kataoka

52 papers receiving 672 citations

Peers

Countries citing papers authored by Tomoko Kataoka

Since Specialization

Citations

This map shows the geographic impact of Tomoko Kataoka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoko Kataoka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoko Kataoka more than expected).

Fields of papers citing papers by Tomoko Kataoka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoko Kataoka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoko Kataoka. The network helps show where Tomoko Kataoka may publish in the future.

Co-authorship network of co-authors of Tomoko Kataoka

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoko Kataoka. A scholar is included among the top collaborators of Tomoko Kataoka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoko Kataoka. Tomoko Kataoka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A randomized phase III trial of postoperative surveillance for pathological stage II and IIIA non-small cell lung cancer (JCOG2012, PHOENIX) 2024 ·Japanese Journal of Clinical Oncology ·Kenta Tane, Satoshi Shiono, Masashi Wakabayashi, Tomoko Kataoka, (unknown), Haruhiko Fukuda, Keiju Aokage, Shun‐ichi Watanabe	1
2	Identification of unapproved orthopedic regenerative medicine: Usefulness of the Act on Safety of Regenerative Medicine 2024 ·Stem Cell Reports ·Yuichiro Ukon, (unknown), (unknown), (unknown), Tomoko Kataoka, (unknown), (unknown), (unknown), Masayuki Furuya, Takahito Fujimori, Takashi Kaito, Kiyoshi Okada, Akira Myoui, Seiji Okada	6
3	Results of a randomized phase II trial of 2nd-line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin and pazopanib: Japan Clinical Oncology Group study JCOG1802 (2ND-STEP). 2024 ·Journal of Clinical Oncology ·Makoto Endo, Toshifumi Fujiwara, Masanobu Takahashi, Satoshi Tsukushi, Akira Kawai, Tabu Gokita, Fumihiko Nakatani, Yutaka Nezu, Takaaki Tanaka, Kenji Nakano, Hiroaki Hiraga, Masashi Wakabayashi, Tomoko Kataoka, (unknown), Haruhiko Fukuda, Yoshinao Oda, Toshifumi Ozaki, Kazuhiro Tanaka	1
4	Carboplatin and irinotecan (CI) vs. carboplatin and etoposide (CE) for the treatment of extended-stage small-cell lung cancer in an elderly population: A phase II/III randomized control trial 2023 ·Lung Cancer ·Tsuneo Shimokawa, Hiroaki Okamoto, Ryunosuke Machida, (unknown), Yukio Hosomi, Yasuto Yoneshima, Hiroshi Tanaka, Kyoichi Okishio, (unknown), Kōichi Goto, Hiroaki Akamatsu, Kaoru Kubota, Kazuhiko Nakagawa, Hidehito Horinouchi, Masahiko Ando, Tomoko Kataoka, Yuichiro Ohe	4
5	A randomized phase II study comparing preoperative mFOLFOX6 versus FOLFOXIRI for locally advanced colon cancer: JCOG2006 2023 ·Future Oncology ·(unknown), Tadayoshi Hashimoto, Satoshi Maruyama, Yasumasa Takii, Junki Mizusawa, Tomoko Kataoka, Haruhiko Fukuda, Shunsuke Tsukamoto, Atsuo Takashima, Tetsuya Hamaguchi, Yukihide Kanemitsu	0
6	Long-term outcome of patients with peripheral ground-glass opacity–dominant lung cancer after sublobar resections 2023 ·Journal of Thoracic and Cardiovascular Surgery ·Ichiro Yoshino, Yasumitsu Moriya, Kenji Suzuki, Masashi Wakabayashi, Hisashi Saji, Keiju Aokage, Makoto Suzuki, Hiroyuki Ito, Isao Matsumoto, (unknown), Tatsuro Okamoto, Morihito Okada, Motohiro Yamashita, Norihiko Ikeda, Shinichiro Nakamura, Tomoko Kataoka, Masahiro Tsuboi, Shun‐ichi Watanabe	12
7	Phase II biomarker identification study of anti-VEGF agents with FOLFIRI for pretreated metastatic colorectal cancer 2023 ·Future Oncology ·Tadayoshi Hashimoto, Satoshi Otsu, Shuichi Hironaka, Atsuo Takashima, Junki Mizusawa, Tomoko Kataoka, Haruhiko Fukuda, Shunsuke Tsukamoto, (unknown), Yukihide Kanemitsu	4
8	Prospective, Multi-Institutional Observational Study of Deterioration in Activities of Daily Living in Elderly Patients After Lung Cancer Surgery 2023 ·JTO Clinical and Research Reports ·Hidefumi Takei, Hideo Kunitoh, Masashi Wakabayashi, Tomoko Kataoka, Yuta Sekino, Tomonori Mizutani, Masahiro Tsuboi, Norihiko Ikeda, Hisao Asamura, Morihito Okada, Makoto Takahama, Yasuhisa Ohde, Jiro Okami, Satoshi Shiono, (unknown), Shun‐ichi Watanabe, Hiroshi Fukuda, Takayuki Shibata	3
9	Study protocol for JCOG1807C (DEEP OCEAN): a interventional prospective trial to evaluate the efficacy and safety of durvalumab before and after operation or durvalumab as maintenance therapy after chemoradiotherapy against superior sulcus non-small cell lung cancer 2022 ·Japanese Journal of Clinical Oncology ·Keiju Aokage, Masahiro Tsuboi, Yoshitaka Zenke, Hidehito Horinouchi, Naoki Nakamura, Satoshi Ishikura, Hiroyoshi Nishikawa, Shogo Kumagai, Shohei Koyama, Keisuke Kanato, Tomoko Kataoka, Masashi Wakabayashi, Miki Fukutani, Haruhiko Fukuda, Yuichiro Ohe, Shun‐ichi Watanabe	5
10	A randomized phase III trial of denosumab before curettage for giant cell tumor of bone. JCOG1610 2022 ·Japanese Journal of Clinical Oncology ·Hiroshi Urakawa, Akihito Nagano, Ryunosuke Machida, Kazuhiro Tanaka, Tomoko Kataoka, Yuta Sekino, Yoshihiro Nishida, Mitsuru Takahashi, Toshiyuki Kunisada, Masanori Kawano, Yukihiro Yoshida, Tatsuya Takagi, Kenji Satô, Toru Hiruma, Koji Hatano, Satoshi Tsukushi, Akio Sakamoto, Toshihiro Akisue, Koji Hiraoka, Toshifumi Ozaki	3
11	Randomized phase III study of etoposide plus cisplatin versus irinotecan plus cisplatin in advanced neuroendocrine carcinoma of the digestive system: A Japan Clinical Oncology Group study (JCOG1213). 2022 ·Journal of Clinical Oncology ·(unknown), Nozomu Machida, Yoshitaka Honma, Takuji Okusaka, Narikazu Boku, Ken Kato, Shogo Nomura, Nobuyoshi Hiraoka, Shigeki Sekine, Hirokazu Taniguchi, (unknown), Kensei Yamaguchi, (unknown), Masafumi Ikeda, Nobumasa Mizuno, Masato Ozaka, Tomoko Kataoka, Yuko Kitagawa, Masanori Terashima, Junji Furuse	4
12	Randomized phase III study of daratumumab versus bortezomib plus daratumumab as maintenance therapy after D-MPB for transplant-ineligible patients with untreated multiple myeloma (JCOG1911, B-DASH study) 2022 ·Japanese Journal of Clinical Oncology ·Tomotaka Suzuki, (unknown), Ryunosuke Machida, Tomoko Kataoka, Yuta Ito, (unknown), Dai Maruyama, Hirokazu Nagai	0
13	Protocol of a randomized phase II/III study of gemcitabine plus nab-paclitaxel combination therapy versus modified FOLFIRINOX versus S-IROX for metastatic or recurrent pancreatic cancer: JCOG1611 (GENERATE) 2022 ·Japanese Journal of Clinical Oncology ·Junki Mizusawa, Akihiro Ohba, Masato Ozaka, Hiroshi Katayama, Takuji Okusaka, Satoshi Kobayashi, Masafumi Ikeda, Takeshi Terashima, Naoki Sasahira, Naohiro Okano, Ikuya Miki, Takashi Kaneko, Nobumasa Mizuno, Akiko Todaka, Masayuki Furukawa, Shinya Kajiura, Tomoko Kataoka, Haruhiko Fukuda, Junji Furuse, Makoto Ueno	1
14	A Multicenter, Randomized Phase III Study Comparing Platinum Combination Chemotherapy Plus Pembrolizumab With Platinum Combination Chemotherapy Plus Nivolumab and Ipilimumab for Treatment-Naive Advanced Non–Small Cell Lung Cancer Without Driver Gene Alterations: JCOG2007 (NIPPON Study) 2021 ·Clinical Lung Cancer ·Yoshimasa Shiraishi, Taiki Hakozaki, Shogo Nomura, Tomoko Kataoka, Kentaro Tanaka, Satoru Miura, Yuta Sekino, Masahiko Ando, Hidehito Horinouchi, Yuichiro Ohe, Isamu Okamoto	18
15	The impact of the COVID-19 outbreak on supportive care for oral mucositis: current concepts and practice 2021 ·Supportive Care in Cancer ·(unknown), Pierluigi Bonomo, Elad Sharon, Tomoko Kataoka, Paolo Bossi	5
16	Study protocol for a multi-institutional randomized phase III study comparing combined everolimus plus lanreotide therapy and everolimus monotherapy in patients with unresectable or recurrent gastroenteropancreatic neuroendocrine tumors; Japan Clinical Oncology Group Study JCOG1901 (STARTER-NET study) 2020 ·Pancreatology ·Ryo Shimoyama, Susumu Hijioka, Nobumasa Mizuno, Gakuto Ogawa, Tomoko Kataoka, Hiroshi Katayama, Nozomu Machida, Yoshitaka Honma, Narikazu Boku, Tetsuya Hamaguchi, Haruhiko Fukuda, Masanori Terashima, Yukihide Kanemitsu, Junji Furuse	7
17	Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines 2019 ·Supportive Care in Cancer ·Catherine Hong, Luiz Alcino Gueiros, Janet S. Fulton, Karis Kin Fong Cheng, Abhishek Kandwal, Dimitra Galiti, Jane M. Fall‐Dickson, Jørgen Johansen, Suzanne Ameringer, Tomoko Kataoka, Dianna Weikel, June Eilers, (unknown), Anusha Vaddi, Rajesh V. Lalla, Paolo Bossi, Elad Sharon	148
18	Randomized trial of standard pain control with or without gabapentin for pain related to radiation-induced mucositis in head and neck cancer 2016 ·Auris Nasus Larynx ·Tomoko Kataoka, Naomi Kiyota, (unknown), Yohei Funakoshi, Naoko Chayahara, Masanori Toyoda, Yutaka Fujiwara, Ken‐ichi Nibu, Takahide Komori, Ryohei Sasaki, Toru Mukohara, Hironobu Minami	27
19	Oral supportive care for cancer patients receiving chemotherapy 2015 ·Annals of Oncology ·Tomoko Kataoka, (unknown), Yohei Funakoshi, (unknown)	0
20	Internal jugular vein patency after modified radical neck dissection in patients with oral cancer 2010 ·Japanese Journal of Oral & Maxillofacial Surgery ·(unknown), Masahiro Umeda, Tsutomu Minamikawa, Tomoko Kataoka, (unknown), Hidenori Takahashi, Yasuyuki Shibuya, Takahide Komori	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact